S&P Ratings Raises India's FY24 Growth Forecast To 6.4%; Cuts FY25 Forecast
S&P Ratings revised its India GDP growth forecast for the current financial year, while lowering it for the year ending March 2025, it stated in a note published on Monday.
"We have revised up our projection for India's GDP growth for FY24 to 6.4%, from 6%, as robust domestic momentum seems to have offset headwinds from high food inflation and weak exports," the global ratings agency stated in a research note on the outlook for Asia-Pacific.
"Still, we expect growth to slow in the second half of the fiscal year amid subdued global growth, a higher base, and the lagged impact of rate hikes," it cautioned. As such, the ratings agency said that it has lowered its outlook for growth in FY25 to 6.4%, from 6.9%.
Meanwhile, China's property weakness continues to weigh on the global economy, the report said, forecasting China's GDP growth at 5.4% in 2023, and 4.6% in 2024. "The latter figure aligns with our estimate of potential growth, suggesting economic slack will persist next year," it added.
Other Asia Pacific economies outside of China remain resilient, according to S&P Ratings. Growth this year and in 2024 should be the strongest in emerging market economies with solid domestic demand in Indonesia, Malaysia, and the Philippines, apart from India, it said.
The composition of the recovery after the pandemic slump differs across the region, the ratings agency said. With the exceptions of Hong Kong and Thailand, GDP exceeded the 2019 level by between 0.1% in Japan and 15.5% in India, in the first half of 2023, it said. In Northeast Asia, India, Australia, and New Zealand fixed investment has recovered considerably more than private consumer spending.
With core inflation continuing to ease, the region's central banks are unlikely to have to tighten monetary policy again, according to the ratings agency. "Still, given the pressure from higher-for-longer U.S. interest rates, we expect no meaningful falls in policy rates for the next six months."
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
